Hypothalamic Hamartomas: Correlation of MR Imaging and Spectroscopic Findings with Tumor Glial Content
D.R. Amstutza,
S.W. Coonsb,
J.F. Kerriganc,
H.L. Rekated and
J.E. Heisermana
a Division of Neuroradiology, Barrow Neurological Institute, Phoenix, Ariz
b Division of Neuropathology, Barrow Neurological Institute, Phoenix, Ariz
c Department of Child Neurology, Barrow Neurological Institute, Phoenix, Ariz
d Division of Neurosurgery, Barrow Neurological Institute, Phoenix, Ariz

View larger version (67K):
[in a new window]
|
Fig 1. Photomicrograph (H&E stain) from predominantly neuronal hypothalamic hamartoma (A) with corresponding single voxel MR spectrum (3T) and axial T2-weighted image (B, -C). The mI peak is moderately elevated and tumor is slightly hyperintense relative to gray matter on T2-weighted images. Also shown are a photomicrograph from a predominately glial hamartoma (D) with corresponding spectrum (1.5T) and T2-weighted images (E,-F). The mI peak is markedly elevated, and the lesion is very hyperintense in comparison to gray matter. Cho is mildly elevated, and NAA is reduced in both cases.
| |

View larger version (9K):
[in a new window]
|
Fig 2. Graph shows the comparison of spectral ratios within tumor and normal gray matter. A significant decrease is noted in NAA/Cr in the hypothalamic hamartomas compared with normal controls. Significant increases are seen in mI/Cr and Cho/Cr. Horizontal dashes represent 95% confidence intervals.
| |

View larger version (8K):
[in a new window]
|
Fig 3. Scatterplot shows individual mI/Cr ratios of hypothalamic hamartomas versus 6-point pathology rating scale (1 = mostly neuronal, 6 = mostly glial). Samples exhibit increased mI concentrations with increasing glial content. One relatively neuronal sample (pathology rating, 2) demonstrates an anomalously high mI/Cr = 1.1.
| |

View larger version (8K):
[in a new window]
|
Fig 4. Graph shows relative T2 hyperintensity of hypothalamic hamartomas versus 6-point pathology rating scale (1 = mostly neuronal, 6 = mostly glial). Data demonstrate increasing T2 intensity with increased tumor glial content. A sample with pathology rating of 2 and an anomalously high T2 ratio of 1.8 is the same sample seen as an outlier in Fig 3 and discussed in the text.
| |